25 studies found for:    MDP
Show Display Options
Rank Status Study
1 Recruiting Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy
Conditions: Muscular Dystrophy;   Duchenne Muscular Dystrophy,
Intervention: Biological: Stem Cell
2 Recruiting F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Condition: Bone Metastases
Intervention: Device: Bone Scan: F18-Fluoride PET/CT or TC-MDP
3 Unknown  F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Conditions: Cancer;   Bone Metastases
Interventions: Device: F-18 PET bone scan;   Device: Tc-99m bone scan
4 Completed
Has Results
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
5 Recruiting Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour;   Breast Cancer;   Malignant Tumor of Colon;   GIST;   Ovarian Cancer
Intervention: Biological: HER-2 vaccine
6 Recruiting Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
7 Unknown  18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
Condition: Cancer
Intervention:
8 Completed A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
Conditions: Cystitis, Interstitial;   Urologic Diseases;   Urinary Bladder Disease;   Pain
Interventions: Drug: ASP3652;   Drug: Placebo
9 Completed Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
Conditions: Bone Metastases;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Procedure: magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Procedure: computed tomography;   Radiation: technetium Tc 99m methylene diphosphonate;   Other: laboratory biomarker analysis
10 Terminated
Has Results
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: Normal saline (Placebo); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (50U); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (100U); botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (200U)
11 Completed
Has Results
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (300U);   Other: Normal Saline (Placebo); botulinum toxin Type A (200U);   Other: Normal Saline (Placebo); botulinum toxin Type A (300U)
12 Completed
Has Results
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A (200U);   Biological: botulinum toxin Type A (300U);   Other: Normal saline (Placebo); botulinum toxin Type A (200U);   Other: Normal saline (Placebo); botulinum toxin Type A (300U)
13 Terminated
Has Results
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
14 Completed
Has Results
Pharmacokinetics/Pharmacodynamics of Albiglutide
Condition: Diabetes Mellitus, Type 2
Intervention: Biological: albiglutide (GSK716155)
15 Recruiting A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Condition: Myelogenous Leukemia, Acute
Interventions: Drug: RO5503781 MDP;   Drug: cytarabine;   Drug: RO5503781 SDP;   Drug: anthracycline
16 Unknown  F18-Flouride PET/CT in Acute Knee Injury
Condition: Knee Injury
Intervention:
17 Recruiting PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
Condition: Cancer
Interventions: Procedure: F-18 NaF/F-18 FDG PET/CT;   Procedure: Whole-body MRI;   Procedure: Tc-99m MDP bone scan
18 Completed Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
Conditions: HIV Infections;   Gonorrhea;   Chlamydial Infections;   Genital Herpes
Interventions: Drug: PRO 2000/5;   Drug: Placebo
19 Active, not recruiting
Has Results
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: incomplete Freund's adjuvant;   Biological: melanoma helper peptide vaccine;   Biological: multi-epitope melanoma peptide vaccine;   Biological: sargramostim;   Biological: tetanus peptide melanoma vaccine
20 Completed Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer
Condition: Osseous Lesions From Metastatic Breast Cancer
Intervention: Radiation: Zometa™

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years